Tusamitamab Ravtansine | Interleukin Related interleukin-related.com

Product Name :
Tusamitamab Ravtansine

Search keywords :
Tusamitamab

drugId :
null

Target Vo:
Carcinoembryonic antigen related cell adhesion molecule 5

Target Vo Short Name :
CEACAM5

Moa_Name:
Carcinoembryonic antigen related cell adhesion molecule 5 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Immunogen Inc

Active Company_Name :
Innovent Biologics(Suzhou) Co Ltd

Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

In Active Indication_Name:
Lung Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
BRCA1 Antibody (YA819)
SQSTM1/p62 Antibody (YA669)
HA tag Antibody (YA856): Anti-HA tag Antibody is a non-conjugated and Rabbit origined monoclonal antibody. It can be used for WB,IP assays in the background of .

Author: Interleukin Related

Related Posts